The economic imperative to conquer diabetes

Diabetes Care

Volumn 31, Issue 3, 2008, Pages 624-626

  Fradkin, Judith ^a   Rodgers, Griffin P ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEATH; DISABILITY; DISEASE ASSOCIATION; EDITORIAL; GLYCEMIC CONTROL; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INCIDENCE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; COST OF ILLNESS; DIABETES MELLITUS; ECONOMICS; NOTE; STATISTICS; UNITED STATES;

COST OF ILLNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HEALTH CARE COSTS; HUMANS; UNITED STATES;

EID: 44449105676     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0088     Document Type: Editorial

References (22)

1. American Diabetes Association: Economic costs of diabetes in the U.S. in 2007. Diabetes Care 31:596-615, 2008
2. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health: Pre-diabetes: impaired glucose tolerance and impaired fasting glucose [article online]. Available from http://diabetes.niddk. nih.gov/dm/pubs/statistics/#3. Accessed 15 January 2008
3. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B, the American Diabetes Association: Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30:753-759, 2007
4. Liu K, Dyer AR, Vu TH, Pirzada A, Manheim LM, Manning WG, Ashraf MS, Garside DB, Daviglus ML: One-hour postload plasma glucose in middle age and medicare expenditures in older age among nondiabetic men and women: The Chicago Heart Association Detection Project in Industry. Diabetes Care 28:1057-1062, 2005
5. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA 290:1884-1890, 2003
6. Vehik K, Hamman RF, Lezotte D, Norris JM, Klingensmith G, Bloch C, Rewers M, Dabelea D: Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth. Diabetes Care 30:503-509, 2007
7. Lee JM, Okumura MJ, Freed GL, Menon RK, Davis MM: Trends in hospitalizations for diabetes among children and young adults: United States, 1993-2004. Diabetes Care 30:3035-3039, 2007
8. Hogan P, Dall T, Nikolov P: Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26:917-932, 2003
9. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ, the American Heart Association, the American Diabetes Association: Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 30:162-172, 2007
10. Gregg EW, Gu Q, Cheng YJ, Narayan KMV, Cowie CC: Mortality trends in men -i and women with diabetes, 1971 to 2000. Ann Intern Med 147:149-155, 2007
11. Fox CS, Coady S, Sorlie PD, D'Agostino RB Sr, Pencina MJ, Vasan RS, Meigs JB, Levy D, Savage PJ: Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 115:1544-1550, 2007
12. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
13. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB: Is glycemic control improving in U.S. adults? Diabetes Care 31:81-86, 2008
14. Ford ES, Li C, Little RR, Mokdad AH: Trends in AlC concentrations among U.S. adults with diagnosed diabetes from 1999 to 2004. Diabetes Care 31:102-104, 2008
15. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, Narayan KM: Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 144:465-474, 2006
16. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
17. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, the Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
18. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997
19. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, the Indian Diabetes Prevention Programme (IDPP): The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:289-297, 2006
20. Ackermann RT, Marrero DG: Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model. Diabetes Educ 33: 69-78, 2007
21. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE, the Diabetes Prevention Program Research Group: The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 142:323-332, 2005
22. Hsu J, Price M, HuangJ, Brand R, Fung V, Hui R, Fireman B, Newhouse JP, Selby JV: Unintended consequences of caps on Medicare drug benefits. N Engl J Med 354: 2349-2359, 2006